Keith Stewart, who runs the Mayo Clinic's Center for Individualized Medicine, says advances in genomic sequencing are changing scientists' and physicians' approach to cancer. Mayo pharmacology professor Richard Weinshilboum sees the day when genomic information is a standard part of electronic health records, but until more is known about the risks of having genetic mutations interpreted, consumers should be careful of what they do with their genetic testing results, says 23andMe vice president Emily Drabant Conley.
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.